WuXi group wrestles with uncertainty over pharma tariffs 藥明合聯再遭股東減持 ADC外包龍頭受關稅拖累?
Drugs services giant WuXi AppTec cashed in a stake in a sister firm to soften the blow from a first round of Trump tariffs, as the pharma sector braces for another barrage. 藥明康德資金流十分充裕,此次減持更像是財務投資的高位套現以及對關稅風險的提前規避。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.